Equity · Healthcare
NUVL
NASDAQNuvalent, Inc.
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for NUVL to draw a line in its place.
as of Jul 14, 2026
NUVL insider trades
NUVL has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 10 December 2025.
Showing the 12 most recent of 26 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 22 compensation filings in this window. The figures above count all of them.
NUVL reported financials
SEC EDGARNUVL reported net income of −$425.4M for the fiscal year ended 31 Dec 2025.
NUVL earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
NUVL institutional holders
SEC EDGAR12 of the 45 institutional funds we track reported a NUVL position for the quarter ended 30 Jun 2026 — a combined $344.3M; the latest of those filings landed 02 Sep 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
- SEC EDGARSEC EDGAR 13F filings
- SEC EDGARValuation computed from SEC EDGAR filings